Related Experiment Video

Updated: May 1, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

6.0K

Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases

Belén Mezquita1, Pau Mezquita2, Montserrat Pau3

  • 1Laboratori de Genètica Molecular, Universitat de Barcelona, IDIBAPS. Casanova 143, 08036 Barcelona, Spain. belenmezquita@ub.edu.

Cells
|April 9, 2014
PubMed

Insights

Src activation is a key driver of cancer, even with short activation periods, promoting cancer stem cells. Intracellular receptor fragments can also activate Src, driving cancer cell invasion and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Src activation is a critical event in cancer development and progression.
  • Tyrosine kinase receptors and intracellular receptor isoforms can activate Src, initiating oncogenic signaling pathways.
  • Cancer stem cells are implicated in tumor initiation, maintenance, and therapeutic resistance.

Purpose of the Study:

  • To investigate the role of intracellular receptor isoforms in Src activation and cancer cell invasion.
  • To explore the regulatory mechanisms of i21-VEGFR-1 expression in breast cancer.
  • To identify potential therapeutic targets for invasive breast cancer.

Main Methods:

  • Utilized truncated KIT (tr-KIT) and intracellular VEGFR-1 (i21-VEGFR-1) isoforms to study Src activation.
  • Assessed cell migration and invasion assays in cancer cells.
  • Investigated the regulation of i21-VEGFR-1 by Notch signaling, miR-200c, and retinoic acid.

Main Results:

  • Intracellular receptor isoforms, tr-KIT and i21-VEGFR-1, activate Src independently of ligand binding.
  • Src activation by i21-VEGFR-1 promotes cancer cell migration and invasion.
  • i21-VEGFR-1 expression is upregulated by Notch signaling and downregulated by miR-200c and retinoic acid in breast cancer cells.

Conclusions:

  • Src activation by intracellular receptor isoforms is a significant mechanism in cancer cell invasion.
  • Targeting Notch signaling or utilizing retinoic acid may offer therapeutic strategies for invasive breast cancer.
  • Understanding Src regulation provides insights into cancer stem cell biology and therapeutic interventions.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.7K
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

10.3K

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

5.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
44.8K